Is it time to replace BASDAI with ASDAS?
Por um escritor misterioso
Descrição
Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor
Use of the BASDAI in Psoriatic Arthritis Patients with and Without
Journal of Rehabilitation Medicine - A three-week
Disease control in patients with ankylosing spondylitis in real
Frontiers The BASDAI Cut-Off for Disease Activity Corresponding
Disease control in patients with ankylosing spondylitis in real
Frontiers The BASDAI Cut-Off for Disease Activity Corresponding
Improved clinical, functional and work outcomes in
PDF) Selecting patients with ankylosing spondylitis for TNF
Comparative effectiveness of secukinumab and adalimumab in
Frontiers The BASDAI Cut-Off for Disease Activity Corresponding
PDF) Spondyloarthritis: is it time to replace BASDAI with ASDAS?
ASAS20/40 response rates and mean change from baseline in BASDAI
Recommendations by the Spanish Society of Rheumatology on the Use
Disease Control Data, Ankylosing Spondylitis
de
por adulto (o preço varia de acordo com o tamanho do grupo)
